Finance

Lists
Q3 2026 earnings • in 3 days
See details
ONCO3:BVMF
Oncoclinicas do Brasil Srvcs Mdcs SA
R$0.77
+1.32%
(+0.0100) 1D
Nov 3, 12:29:42 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO3...
Open
R$0.79
High
R$0.81
Low
R$0.74
Mkt. cap
874.02M
Avg. vol.
7.97M
Volume
2.34M
52-wk high
R$3.07
52-wk low
R$0.53
EPS
-R$5.60
Shares outstanding
1.14B
Open
R$0.79
High
R$0.81
Low
R$0.74
Mkt. cap
874.02M
Avg. vol.
7.97M
Volume
2.34M
52-wk high
R$3.07
52-wk low
R$0.53
EPS
-R$5.60
Shares outstanding
1.14B
News stories
From web sources and news partners
About Oncoclinicas do Brasil Srvcs Mdcs SA
CEOBruno Lemos Ferrari
Employees-
Founded2010
Headquarters-
SectorHealth care provider
Websitegrupooncoclinicas.com
Next call in 3 days
Fri, Nov 6, 7:00 AM
Fiscal period
Q3 2026
- /
Revenue / Est. (BRL)
- / 1.31B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41B
1.37B
1.16B
1.05B
Cost of goods sold
959.85M
887.92M
961.32M
818.44M
Cost of revenue
959.85M
887.92M
961.32M
818.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
283.58M
366.58M
313.07M
315.35M
Operating expense
1.89B
514.52M
481.09M
519.42M
Total operating expenses
2.85B
1.40B
1.44B
1.34B
Operating income
-1.43B
-33.61M
-281.64M
-290.11M
Other non operating income
-9.60M
-568.93M
-91.29M
-4.84M
EBT including unusual items
-1.85B
-1.09B
-496.74M
-483.15M
EBT excluding unusual items
-1.63B
-606.65M
-493.21M
-479.97M
Income tax expense
26.67M
429.22M
2.56M
-7.42M
Effective tax rate
-1.44%
-39.49%
-0.51%
1.53%
Other operating expenses
1.60B
147.94M
168.02M
204.07M
Net income
-1.88B
-1.45B
-424.85M
-468.99M
Net profit margin
-133.22%
-106.22%
-36.60%
-44.76%
Earnings per share
-0.15
-0.34
-0.40
-0.72
Interest and investment income
44.65M
1.45M
5.37M
2.76M
Interest expense
-230.76M
-6.99M
-131.22M
-163.83M
Net interest expenses
-186.11M
-5.54M
-125.85M
-161.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.39B
13.39M
-241.09M
-253.64M
Gain or loss from assets sale
466.21M
-31.88M
-11.81M
11.81M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps